Zoom Logo

Danya Adams' Personal Meeting Room - Shared screen with speaker view
Layan Shahrour
47:44
GSR Journal would like to remind the audience that we are currently accepting submissions for primary research articles, mini-reviews, and hypotheses-driven articles. Submissions are due by the end of Saturday. To find more information, please visit our website at www.gsrjournal.org.If you have any questions that you would like us to ask the panelists at the end please private message them to Danya. There will also be the chance for the audience to ask panelists questions themselves at the end if they hold on to their questions.
Layan Shahrour
49:25
How does your field relate to vaccine development?
Layan Shahrour
51:25
When trying to make a vaccine, where does a researcher begin? What are some of the main questions researchers ask?
Layan Shahrour
53:35
Research is a very trial and error field. If the first trials do not turn out as expected, how do researchers build upon what they learned in order to continue their research?
Layan Shahrour
56:57
Research is a team effort sport. What are some of the ways you collaborate with other labs when trying to develop a potential vaccine?
Layan Shahrour
01:00:45
Recently, we have heard a lot about accelerated vaccine trials using combined phases. Should all vaccines in the future undergo combined phases, or do you think this hinders vaccine quality?On top of that, due to a rushed timeline, many pharmaceutical companies skipped preclinical animal testing. Why is preclinical animal testing so important and do you think it is an important step for clinical trials?
Layan Shahrour
01:13:48
What are some legal concerns normally regarding vaccine delivery?
Layan Shahrour
01:17:57
Can you talk a little bit about “immunity passports’? If this were to be enacted, what are the implications and potential challenges?
Layan Shahrour
01:24:28
There are some concerns regarding the anti vax community and how they may respond to the release of the COVID-19 vaccine, how do you think that will affect the fight against COVID-19? (in terms of herd immunity, immunocompromised people, etc.)
Layan Shahrour
01:29:12
How can someone with lower health literacy avoid misinformation about the COVID-19 vaccine, whether it’s from a scientific article or general social and news media? (in regard to political and scientific distrust)
Layan Shahrour
01:36:18
Pfizer and Moderna both announced vaccines that were developed using mRNA technology. Can you tell us a little bit about how this new type of vaccine works and what its benefits are as compared to conventional vaccines, in terms of efficacy, administration, and distribution?
Layan Shahrour
01:41:15
If you have any questions you would like to ask, please raise your virtual hand and we will call on your or please send Danya your questions in the chat
Alexandra PHELAN (she/her)
01:47:37
A good briefing on the scope of the PREP Act (& COVID19 countermeasure liability waivers):
Alexandra PHELAN (she/her)
01:47:38
https://www.hoganlovells.com/~/media/hogan-lovells/pdf/2020-pdfs/2020_03_23_liability_immunity_under_the_prep_act-for_covid_19_countermeasures.pdf
Layan Shahrour
01:48:23
We will be having more events in the spring semester so follow our instagram @gsrjournal to stay updated!